CYBERGUN SA (ALCYB.PA)
FR0014004QR6 - Common Stock
We assign a fundamental rating of 1 out of 10 to ALCYB. ALCYB was compared to 15 industry peers in the Leisure Products industry. ALCYB may be in some trouble as it scores bad on both profitability and health. ALCYB does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ALCYB had negative earnings in the past year.
In the past year ALCYB has reported a negative cash flow from operations.
In the past 5 years ALCYB reported 4 times negative net income.
In the past 5 years ALCYB always reported negative operating cash flow.
1.2 Ratios
ALCYB has a worse Return On Assets (-25.18%) than 92.86% of its industry peers.
With a Return On Equity value of -90.14%, ALCYB is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.18% | ||
| ROE | -90.14% | ||
| ROIC | N/A |
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALCYB has a Gross Margin of 40.24%. This is comparable to the rest of the industry: ALCYB outperforms 42.86% of its industry peers.
In the last couple of years the Gross Margin of ALCYB has grown nicely.
ALCYB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
2. Health
2.1 Basic Checks
ALCYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALCYB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALCYB has been increased compared to 5 years ago.
Compared to 1 year ago, ALCYB has a worse debt to assets ratio.
2.2 Solvency
ALCYB has an Altman-Z score of -0.12. This is a bad value and indicates that ALCYB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.12, ALCYB is doing worse than 92.86% of the companies in the same industry.
ALCYB has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.12, ALCYB belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.12 |
ROIC/WACCN/A
WACC3.51%
2.3 Liquidity
ALCYB has a Current Ratio of 1.13. This is a normal value and indicates that ALCYB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALCYB (1.13) is worse than 78.57% of its industry peers.
A Quick Ratio of 0.49 indicates that ALCYB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.49, ALCYB is doing worse than 92.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
ALCYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3399.84%.
Looking at the last year, ALCYB shows a decrease in Revenue. The Revenue has decreased by -1.46% in the last year.
Measured over the past years, ALCYB shows a small growth in Revenue. The Revenue has been growing by 5.94% on average per year.
EPS 1Y (TTM)-3399.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1588.5%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-29.54%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ALCYB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ALCYB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CYBERGUN SA
EPA:ALCYB (9/13/2024, 7:00:00 PM)
0.0001
0 (0%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap122.89K
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.18% | ||
| ROE | -90.14% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.24% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-3399.84%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y